Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing
June 10, 2024 01:00 ET
|
Biocartis NV
PRESS RELEASE - 10/06/2024, 07:00 CEST Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing Mechelen, Belgium 10 June 2024 – Biocartis NV...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm
June 07, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Global Digital Diagnostics Market Report 2024-2034: Analysis & Forecast by Product, Diagnosis Type, End-user & Region, Featuring Profiles of Laboratory Corp of America, Digital Diagnostics Inc, GE Healthcare
June 05, 2024 05:43 ET
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Digital Diagnostics Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global digital...
ZSFab Announces First U.S. Clinical Use of InterConnect™ 3D Printed Ti Lumbar Interbody System
June 04, 2024 13:45 ET
|
ZSFab, Inc.
ZSFab Announces First U.S. Clinical Use of InterConnect™ 3D Printed Ti Lumbar Interbody System
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm
June 03, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
June 03, 2024 04:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
June 01, 2024 08:00 ET
|
Kymera Therapeutics, Inc.
KT-253 demonstrates initial clinical proof of concept in patients with tumor types shown to be sensitive in preclinical models, including responses in MCC and AML Evidence of target engagement...
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
May 30, 2024 09:15 ET
|
Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics
Global Blood Screening Market Size To Exceed USD 5.1 Billion By 2033 | CAGR Of 7.39%
May 30, 2024 08:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 30, 2024 (GLOBE NEWSWIRE) -- The Global Blood Screening Market Size is to Grow from USD 2.5 Billion in 2023 to USD 5.1 Billion by 2033, at a Compound Annual Growth Rate...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Ocugen, Sonder, and QuidelOrtho Innovations and Encourages Investors to Contact the Firm
May 29, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...